Navigation Links
Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report
Date:11/13/2008

Survey of industry executives identifies risks and opportunities in global pharma

NEW YORK, Nov. 13 /PRNewswire/ -- Leaders of the largest global pharmaceutical companies recognize the need for transformational change in their organizations, but will need to move swiftly to ensure sustained growth for the sector. Current global financial conditions and the threat of a broad recession have accelerated the timetable for implementing change, as the industry confronts lower corporate stock prices and an increasingly cost-averse customer. These and other findings were released today in Progressions, Executing for success: powering new business models, Ernst & Young's bi-annual global pharmaceutical report.

The Progressions report reveals findings from a global survey of senior executives from 15 major pharmaceutical companies. It identifies the top concerns of these leaders and the progress they have made in transforming their businesses.

The industry faces unprecedented challenges related to patent expirations, pricing and regulatory pressures, thin late-stage pipelines, shifting demographics, efficacy issues and globalization. While the majority of companies have announced major strategic shifts and choices that have the potential of transforming the business and the business model, most have yet to adopt the organizational and functionality changes needed to power these new models, the report says.

"All of the top 15 pharmaceutical companies have undergone senior executive-level changes within the last two years, bringing in an influx of new C-suite talent that includes many individuals from industries that have successfully tackled the challenges now confronting Pharma," said Carolyn Buck Luce, Global Pharmaceutical Leader, Ernst & Young. "These leadership changes should help innovative companies to transform their finance function, organizational design, and business models in ways that enable them to continue to prosper in a chall
'/>"/>

SOURCE Ernst & Young
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ould identify those who would benefit from liver s...ESDAY, Dec. 1 (HealthDay News) -- A CT scan of liv...r may help predict overall survival after chemothe...(Avastin) to cytotoxic chemotherapy has been shown...olorectal cancer and to produce better results in ...
(Date:12/1/2009)... Practitioners of any medi...nscription are breathing a sigh of relief this wee...Phone. The application, released over the holiday...anscribe voice recordings to do so quickly and sea... (PRWEB) December 1, 2009 -- The ...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog...
(Date:12/1/2009)..., , FORT LAUDERDALE, Fla., Dec. 1 /PRNews... of patient enrollment in the randomized clinical ...g Stent (Combo Stent). ,, A prospective, random... E valuation of an ablu M inal sirolimus coat ... patients at up to 20 sites in Asia, Australia, Eu...
(Date:12/1/2009)... Montreal, December 1, 2009 A Universit de Montra...arch Center on Family Violence and Violence Agains...ffects of pornography on men. "We started our rese...onsumed pornography. We couldn,t find any," says S...professor at the School of Social Work. , "The ...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Are the effects of pornography negligible? 2
...C., Oct. 30 It,s no secret that,companies rely he... top,talent. But best-in-class organizations have ... hiring opportunities, according to research from,...izations and, ultimately, into their,work forces. ...
..., Oct. 30 West Anaheim Medical,Center, an affilia...nstalled a state-of-the-art patient tracking and i...ent. Housed within the hospital,s MEDITECH,system,... and efficiently. This patient safety process take...
...A) Specifically aimed, stereotactic radiation may ...ter in treating benign but potentially devastatin...cording to a study by rradiation oncologists at th...ent is effective and the only way to remove the t...
...erts from the U.S Centers for Disease Control, Uni...: HIV Symposium at Association for Molecular Patho...Nov. 7, 9:00 to 10:00 am , Where: Hyatt Regency ... been concerned about HIVs ability to mutate and c...
... and analysis reveal how salaries measure up acros...LADELPHIA, Oct. 30 Case in Point Magazine announc...and Trends Survey.,Presenting professional demogra...prevailing trends. Anne Llewellyn,RN-BC, MS, BHSA,...
... Oct 30 Perrigo Company,(Nasdaq: PRGO ; TASE) to... a,quarterly dividend of $0.05 per share, payable ...November 23, 2007. The new quarterly dividend of,$...care supplier that develops,manufactures and distr...
Other Medicine News:Health News:Lessons Learned in Securing Top Talent During University Recruiting 2Health News:Hospital Launches State-of-the-Art Patient Tracking and Integrated Patient Data System 2Health News:Jefferson oncologists show focused radiation is effective as surgery against nerve tumor 2Health News:Case in Point Magazine Releases 2007 Case Management Salary and Trends Survey 2
(Date:12/1/2009)... , ATLANTA, Dec. 1 C...edical device and cardiovascular tissue processing... for 2010. ,, The Company expects total revenue...illion and $123.0 million, which includes between ...eceived from the Department of Defense in connecti...
(Date:12/1/2009)... , PISCATAWAY, N.J., Dec. 1 ...ens.com/hearing) a leading global manufacturer of ...rtnership with Quota International,s Sound Beginni...h September 2010. ,, As part of the renewed par...ide vouchers for 100 free hearing instruments to b...
(Date:12/1/2009)... , BEIJING, Dec. 1 /PRNewswire-Asia/ ...provider of biopharmaceutical products in China, a...chase order for its H1N1 vaccine, PANFLU.1(TM),fr...chnology for the national,purchase plan. Under thi...n,additional one million doses of PANFLU.1 (TM) (1...
Breaking Medicine Technology:CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Nothing But Nets Delivers Anti Malaria Nets to Children and Families in Uganda 60146 1Nothing But Nets Delivers Anti Malaria Nets to Children and Families in Uganda 60146 2Nothing But Nets Delivers Anti Malaria Nets to Children and Families in Uganda 60146 3Radiation From Medical Scans Soaring 60144 1Radiation From Medical Scans Soaring 60144 2Radiation From Medical Scans Soaring 60144 3Relevant Security and bitRail Debut RevSecure Product Line 60142 1Relevant Security and bitRail Debut RevSecure Product Line 60142 2Relevant Security and bitRail Debut RevSecure Product Line 60142 3Relevant Security and bitRail Debut RevSecure Product Line 60142 4
...fered as 1-piece or modular, in regular or extra l...ized with handles of choice and other options such...ndard patterns are available from Mediflex stock. ... , Please Note: Individual instrument components...
10 mm Babcock-Debakey Forceps
Babcock Grasper
...ts incorporate a layered design unique in the indu...o prevent stray electrosurgical burns along the sh... or capacitive coupling; a well-documented patient... AEM Instruments provides a neutral return path fo...
Medicine Products: